CAXTON CORP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | RZLT | 1.99M | $18.68M |
 | CMPX | 54K | $187.26K |
 | MNMD | 27K | $318.46K |
 | KYTX | 23K | $137.89K |
 | CNTX | 18K | $17.83K |
 | LXEO | 17K | $115.08K |
 | IKT | 16K | $26.56K |
 | ELVN | 13K | $268.11K |
 | BCAX | 11K | $172.76K |
 | SABS | 11K | $21.98K |
 | BRK-B | 651 | $327.45K |
Rezolute, Inc.
RZLT
Shares Held
1.99M
Value
$18.68M
Compass Therapeutics, Inc.
CMPX
Shares Held
54K
Value
$187.26K
Mind Medicine (MindMed) Inc.
MNMD
Shares Held
27K
Value
$318.46K
Kyverna Therapeutics, Inc.
KYTX
Shares Held
23K
Value
$137.89K
Context Therapeutics Inc.
CNTX
Shares Held
18K
Value
$17.83K
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
17K
Value
$115.08K
Inhibikase Therapeutics, Inc.
IKT
Shares Held
16K
Value
$26.56K
Enliven Therapeutics, Inc.
ELVN
Shares Held
13K
Value
$268.11K
Bicara Therapeutics Inc. Common Stock
BCAX
Shares Held
11K
Value
$172.76K
SAB Biotherapeutics, Inc.
SABS
Shares Held
11K
Value
$21.98K
Berkshire Hathaway Inc.
BRK-B
Shares Held
651
Value
$327.45K